Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Non-Current Deferred Tax Liability (2022 - 2024)

Historic Non-Current Deferred Tax Liability for Mainz Biomed (MYNZ) over the last 3 years, with Q2 2024 value amounting to $116679.0.

  • Mainz Biomed's Non-Current Deferred Tax Liability rose 886626.6% to $116679.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $116679.0, marking a year-over-year increase of 886626.6%. This contributed to the annual value of $138889.0 for FY2023, which is 3035.0% down from last year.
  • Mainz Biomed's Non-Current Deferred Tax Liability amounted to $116679.0 in Q2 2024, which was up 886626.6% from $138889.0 recorded in Q4 2023.
  • Over the past 5 years, Mainz Biomed's Non-Current Deferred Tax Liability peaked at $199410.0 during Q4 2022, and registered a low of -$1331.0 during Q2 2023.
  • Its 3-year average for Non-Current Deferred Tax Liability is $90467.4, with a median of $116679.0 in 2024.
  • In the last 5 years, Mainz Biomed's Non-Current Deferred Tax Liability tumbled by 3035.0% in 2023 and then skyrocketed by 886626.6% in 2024.
  • Over the past 3 years, Mainz Biomed's Non-Current Deferred Tax Liability (Quarter) stood at $199410.0 in 2022, then crashed by 30.35% to $138889.0 in 2023, then dropped by 15.99% to $116679.0 in 2024.
  • Its Non-Current Deferred Tax Liability was $116679.0 in Q2 2024, compared to $138889.0 in Q4 2023 and -$1331.0 in Q2 2023.